Financials

  • Market Capitalization 75.47 M
  • Employee 24
  • Founded 2011
  • CEO N/A
  • Website www.neuraxis.com
  • Headquarter Delaware, United States
  • FIGI BBG01C9N12C3
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.49
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4048
GANX
Gain Therapeutics, Inc. - Common Stock
1.80 USD-1.10%+1.69%+1.12%+1.69%78.56 M USD
4060
RNTX
Rein Therapeutics, Inc. - Common Stock
0.89 USD+5.95%+15.58%+23.61%-19.11%76.78 M USD
4082
CING
Cingulate Inc. - Common Stock
5.10 USD-2.30%-4.32%+3.03%-17.21%74.16 M USD
4083
CALC
CalciMedica, Inc. - Common Stock
2.17 USD-1.36%-5.65%+193.24%-30.23%74.09 M USD

Noticias